Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure

Major Depression ◽

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Circulation ◽

10.1161/01.cir.79.3.491 ◽

1989 ◽

Vol 79 (3) ◽

pp. 491-502 ◽

Cited By ~ 153

Author(s):

H Drexler ◽

U Banhardt ◽

T Meinertz ◽

H Wollschläger ◽

M Lehmann ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Converting Enzyme ◽

Long Term Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: a double-blind, placebo-controlled trial

Research in Veterinary Science ◽

10.1016/s0034-5288(03)00111-5 ◽

2003 ◽

Vol 75 (3) ◽

pp. 195-201 ◽

Cited By ~ 6

Author(s):

Anna Tidholm ◽

T Falk ◽

S Gundler ◽

H Svensson ◽

B Åblad ◽

...

Keyword(s):

Heart Failure ◽

Thyroid Hormone ◽

Myocardial Dysfunction ◽

Controlled Trial ◽

Double Blind ◽

A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure

American Heart Journal ◽

10.1016/0002-8703(92)90752-h ◽

1992 ◽

Vol 123 (1) ◽

pp. 95-103 ◽

Cited By ~ 34

Author(s):

Stuart D. Katz ◽

Spencer H. Kubo ◽

Mariell Jessup ◽

Suzanne Brozena ◽

Janice M. Troha ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Severe Congestive Heart Failure ◽

Double Blind ◽

Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial – Expression of concern

British Journal Of Nutrition ◽

10.1017/s0007114521002063 ◽

2021 ◽

pp. 1-1

Author(s):

Fariba Raygan ◽

Milad Behnejad ◽

Vahidreza Ostadmohammadi ◽

Fereshteh Bahmani ◽

Mohammad A Mansournia ◽

...

Keyword(s):

Heart Failure ◽

Insulin Resistance ◽

Controlled Trial ◽

Selenium Supplementation ◽

Metabolic Risk ◽

Double Blind ◽

Invited commentary in response to: selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial

British Journal Of Nutrition ◽

10.1017/s0007114518001228 ◽

2018 ◽

Vol 120 (1) ◽

pp. 1-2 ◽

Cited By ~ 1

Author(s):

Wen-Hsing Cheng ◽

Gerald F. Combs

Keyword(s):

Heart Failure ◽

Insulin Resistance ◽

Controlled Trial ◽

Selenium Supplementation ◽

Metabolic Risk ◽

Double Blind ◽

The Targeting Acute Congestion with Tolvaptan in Congestive Heart Failure Study: A Randomized, Double blind, Placebo-Controlled Trial in Acute Heart Failure

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2016.09.010 ◽

2016 ◽

Vol 22 (11) ◽

pp. 939

Author(s):

Robert J. Mentz ◽

G. Michael Felker ◽

Robert Cole ◽

Kirkwood F. Adams ◽

Gregory Egnaczyk ◽

...

Keyword(s):

Heart Failure ◽

Acute Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiop

European Journal of Heart Failure ◽

10.1016/s1388-9842(03)00105-3 ◽

2003 ◽

Vol 5 (5) ◽

pp. 679-691 ◽

Cited By ~ 40

Author(s):

F. Waagstein ◽

O. Strömblad ◽

B. Andersson ◽

M. Böhm ◽

M. Darius ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Controlled Trial ◽

Term Treatment ◽

Double Blind ◽

Double Blind Placebo ◽

Moderate Heart Failure ◽

Long Term Treatment

Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double‐blind, placebo‐controlled trial

European Journal of Heart Failure ◽

10.1002/ejhf.1591 ◽

2019 ◽

Vol 21 (11) ◽

pp. 1426-1433 ◽

Cited By ~ 6

Author(s):

Adriaan A. Voors ◽

Jeroen J. Bax ◽

Adrian F. Hernandez ◽

Antonieta B. Wirtz ◽

Akos F. Pap ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Agonist ◽

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Reduced Ejection Fraction ◽

Adenosine A1 ◽

A1 Receptor

Central and regional hemodynamic effects of oral enoximone in congestive heart failure: A double-blind, placebo-controlled study

American Heart Journal ◽

10.1016/0002-8703(88)90076-2 ◽

1988 ◽

Vol 115 (5) ◽

pp. 1051-1059 ◽

Cited By ~ 20

Author(s):

Carl V. Leier ◽

John J. Lima ◽

Steffen E.L. Meiler ◽

Donald V. Unverfeth

Keyword(s):

Heart Failure ◽

Controlled Study ◽

Hemodynamic Effects ◽

Double Blind ◽

The Effects of METhotrexate Therapy on the Physical Capacity of Patients With ISchemic Heart Failure: A Randomized Double-Blind, Placebo-Controlled Trial (METIS Trial)

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2009.06.439 ◽

2009 ◽

Vol 15 (10) ◽

pp. 828-834 ◽

Cited By ~ 24

Author(s):

Daniel Medeiros Moreira ◽

Jefferson Luís Vieira ◽

Carlos Antônio Mascia Gottschall

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Physical Capacity ◽

Ischemic Heart ◽

Ischemic Heart Failure ◽

Double Blind ◽